About this raise

Fisher Wallace Laboratories, with a valuation of $83.08 million, is raising funds on StartEngine through Reg A+ crowdfunding. The company manufactures and sells wearable medical devices for mood and sleep disorders, including insomnia, anxiety, and depression. The product of Fisher Wallace Laboratories, the Fisher Wallace Stimulator, stimulates the brain to produce serotonin and modulates brainwave activity. The company has generated $40 million in lifetime revenue and has 14,000 prescribers and 100,000 customers. Kelly Roman and Charles Fisher founded Fisher Wallace in August 2019. The current crowdfunding campaign has a maximum target of $10.35 million. The campaign proceeds will be used for research and development, working capital, company employment, and marketing.

Expand

Investment Overview

Invested this round: $493,354

Deal Terms

Total Commitments

Platform
StartEngine
Start Date
02/24/2023
Close Date
Not Provided
Min. Goal
$491
Max Goal
$10,350,000
Min. Investment

$491

Security Type

Equity - Common

Series

Series B

SEC Filing Type

RegA+    Open SEC Filing

Price Per Share

$10.67

Pre-Money Valuation

$100,280,000

Company & Team

Company

Year Founded
2019
Industry
Fitness & Wellness
Tech Sector
Medtech
Distribution Model
B2C
Margin
High
Capital Intensity
High
Location
Brooklyn, New York
Business Type
Growth
Company Website
Visit Website

Team

Employees
10
Prior Founder Exits?
No
Founder Name
Kelly Roman
Title
CEO
Founder Name
Charles Fisher
Title
Chairman, Director, & President

Financials

 Revenue -0% YoY
$4,230,290
 Monthly Burn
Profitable
 Cash on Hand
$1,929,380

Balance Sheet

Cash and Cash Equivalents

$1,929,380

Total Assets

$1,999,403

Accounts Payable & Accrued Liabilities

$966,198

Long Term Debt

$576,525

Total Liabilities

$1,542,723

Total Stockholders' Equity

$456,680

Total Liabilities and Equity

$1,999,403

Statement of Comprehensive Income Information

Total Revenues

$4,230,290

Costs & Expenses Applicable to Rev

$623,703

Net Income

$3,606,587

Earnings Per Share - Basic

$-0.47

Earnings Per Share - Diluted

$-0.47

Auditor: IndigoSpire CPAs & Advisors
Create a free account today to gain access to Kingscrowd analytics and financials.

Upgrade to gain access

Pay Monthly
Annually (2 months free)

Edge

$12.50 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific Kingscrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.

Ratings Kingscrowd Startup Rating Methodology Article

Blurred Ratings Bars Blurred Ratings Bars

Company Funding & Growth

Funding history

Total Prior Capital Raised
$10,000,000
VC Backed?
Yes
Offering Name Close Date Platform Valuation Total Raised Security Type Status Reg Type
Fisher Wallace Labs 01/02/2025 DealMaker Securities $108,250,000 $217,434 Equity - Common Funded RegCF
Fisher Wallace Labs 10/17/2024 DealMaker Securities $106,700,000 $276,274 Equity - Common Funded RegCF
Fisher Wallace 07/02/2024 DealMaker Securities $106,000,000 $237,234 Equity - Common Funded RegCF
Fisher Wallace 04/18/2024 DealMaker Securities $104,100,000 $413,448 Equity - Common Funded RegCF
Fisher Wallace 03/12/2024 DealMaker Securities $102,658,809 $469,069 Equity - Common Funded RegCF
Fisher Wallace 01/24/2024 DealMaker Securities $102,170,000 $532,202 Equity - Common Funded RegCF
Fisher Wallace Laboratories 10/04/2023 StartEngine $100,280,000 $493,354 Equity - Common Funded RegA+
Fisher Wallace 02/20/2023 StartEngine $81,567,588 $1,281,201 Equity - Common Funded RegCF
Fisher Wallace Laboratories 09/01/2022 StartEngine $81,236,323 $357,719 Equity - Common Funded RegCF
Fisher Wallace Laboratories 05/27/2022 StartEngine $80,048,889 $1,279,724 Equity - Common Funded RegCF
Fisher Wallace Laboratories 10/26/2021 StartEngine $40,000,000 $5,010,683 Equity - Common Funded RegA+
Fisher Wallace Laboratories 03/09/2020 StartEngine $15,000,000 $1,056,480 Equity - Common Funded RegCF
Create a free account today to gain access to Kingscrowd analytics.

Growth Charts

Revenue History

Note: Revenue data points reflect the latest of either the most recent fiscal year's financials, or updated revenues directly from the founder, at each raise's close date.

Valuation History

Price per Share History

Note: Share prices shown in earlier rounds may not be indicative of any stock splits.

Employee History

Founders: enhance your startup's credibility on Kingscrowd. Create an account to claim this raise page.
Add to portfolio
Fisher Wallace Laboratories on StartEngine 2023
Platform: StartEngine
Security Type: Equity - Common
Valuation: $100,280,000
Price per Share: $10.67

Follow company

Follow Fisher Wallace Laboratories on StartEngine 2023

Buy Fisher Wallace Laboratories's Deal Report

Warning: according to the close date for this deal, Fisher Wallace Laboratories may no longer be accepting investments.

Fisher Wallace Laboratories Deal Report

Get Kingscrowd's comprehensive report on Fisher Wallace Laboratories including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether Fisher Wallace Laboratories is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise

Buy the Fisher Wallace Laboratories deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge